(19)
(11) EP 4 149 479 A1

(12)

(43) Date of publication:
22.03.2023 Bulletin 2023/12

(21) Application number: 21731832.8

(22) Date of filing: 14.05.2021
(51) International Patent Classification (IPC): 
A61K 31/56(2006.01)
A61K 31/575(2006.01)
 A61K 31/569(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/575; A61K 31/569; A61K 31/56; A61P 31/14
 
C-Sets:
  1. A61K 31/56, A61K 2300/00;
  2. A61K 31/569, A61K 2300/00;
  3. A61K 31/575, A61K 2300/00;
(86) International application number:
PCT/IB2021/054142
(87) International publication number:
WO 2021/229519 (18.11.2021 Gazette 2021/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.05.2020 IT 202000011092

(71) Applicant: Bar Pharmaceuticals Società A Responsabilità Limitata
42124 Reggio Nell'Emilia (IT)

(72) Inventors:
  • ZAMPELLA, Angela
    80127 Napoli (IT)
  • CATALANOTTI, Bruno
    42124 Reggio Nell'Emilia (IT)
  • FIORUCCI, Stefano
    06100 Perugia (IT)

(74) Representative: Studio Torta S.p.A. 
Via Viotti, 9
10121 Torino
10121 Torino (IT)

   


(54) STEROLS IN THE TREATMENT AND/OR PREVENTION OF SARS-COV-2 INFECTION